Email:
|
zuzana.solarova@upjs.sk | |
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/zuzana.solarova | |
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
Department:
|
UFR
-
Department of Pharmacology
|
|
Office:
|
||
Phone:
|
||
ORCID ID:
|
https://orcid.org/0000-0002-4212-5720 |
Overview of the responsibility for
the delivery, development and quality assurance of the study programme or its part
at the university in the current academic year
|
Study programme: medical pharmacology - 1,2, study field: pharmacy, member of the commission degree
|
Profile courses
|
pharmacology 2 - VL, I. + II. degree
|
pharmacology 2 - GM, I. + II. degree
|
pharmacology 2 - DM, I. + II. degree
|
medical pharmacology - PhD., III. degree
|
farmakológia 2 - ZL, I. + II. degree
|
Selected publications
|
ADC. Kimáková P. , Solár P. , Solárová Z. , Komel R. , Debeljak N. : Erythropoietin and its angiogenic activity. International Journal of Molecular Sciences. - ISSN 1422-0067. - Vol. 18, no. 7 (2017), art.no. 1519. (IF=3,687; Q1); cit. 37x |
ADC: Zuzana Solárová, Martin Kello, Lenka Varinská, Marianna Budovská, Peter Solár : Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluorophenylamino)- 4H-1,3-thiazine[6,5-b]indole in A2780cis cells. Biomedicine & Pharmacotherapy. - ISSN 0753-3322. - Vol. 85 (2017), p. 463-471. (IF=3,457; Q1 - SJR) cit. 5 x. |
Solár P. , Hrčková G. , Koptašíková L. , Velebný S. , Solárová Z. , Bačkor M. : Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: anticancer and hepatoprotective effects of atranorin in vivo. Chemico-Biological Interactions. - ISSN 0009-2797. - Vol. 250 (2016), s. 27-37, (IF=3,143; Q2) cit. 8x |
ADM: Solárová Z., Lisková A., Samec M., Kubatka P., Solár P.: Anticancer potential of lichens’ secondary metabolites. Biomolecules – ISSN 2218273X. – Vol. 10, no. 1 (2020), p. (IF=4,879; Q2 - JCR), cit. 26 x. |
Selected projects
|
1. APVV-16-0446 Grant name: Cell interactions in tumor microenvironment ant its pharmacologic affecting. Grant supervisor: RNDr. Lenka Varinská, PhD. Duration: 1.7.2017-30.6.2021 Participation: member (2017-2021) |
2.VEGA 1/0299/13 Grant name: The role of galectins in angiogenesis. Grant supervisor: RNDr. Lenka Varinská, PhD. Duration: 1.7.2013-30.6.2017 Participation: member (2013-2017) |
3. VEGA 1/0394/15 Grant name: Erythropoietin receptor in mammary adenocarcinoma and its role in resistance to tamoxifen. Grant supervisor: Doc. RNDr. Peter Solár, PhD. Duration: 01/2015-12/2018 Participation: member (2015-2018) |
4. VEGA 1/0536/19 Grant name: The role of erythropoietin receptor in the response of mammary adenocarcinoma cells to paclitaxel in vitro and in vivo. Grant supervisor: Doc. RNDr. Peter Solár, PhD. Duration: 01/2019-12/2022 Participation: member (2019-till now) |
International mobilities and visits
|
University in Ljubljana, Slovenia, Medical faculty of Ljubljana university, July of 2019, Erasmus teacher's mobility
|
Projects
|
1. APVV-16-0446 Cell interactions in the tumor microenvironment and their pharmacological influence, member of the research team (2017-2021) 2. VEGA 1/0733/12 Typification of human erythropoietin receptor in cancer and normal cells, member of the research team (2012-2014) 3. VEGA 1/0394/15 Erythropoietin receptor in mammary adenocarcinoma and its role in resistance to tamoxifen, member of the research team (2015-2018) 4. VEGA 1/0536/19 The role of erythropoietin receptor in the response of mammary adenocarcinoma cells to paclitaxel in vitro and in vivo, member of the research team (2019-untill now)
|
International collaboration
|
University of Ljubljana, Ľubľana , Slovinsko
|
Interesting links
|
www.biomednet.com www.elsevier.nl www.ncbi.nlm.nih.gov
|